IGF2BP2 and breast cancer: Recent experimental data underscore a connection between IGF2BP2 and the development of various cancers [19, 21], including hepatocellular carcinoma [22], breast cancer [23], ovarian cancer [24], colon cancer [25], and esophageal cancer [26].